Lv11
20 积分 2025-04-21 加入
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2
3小时前
已完结
Nouvelle AMM : trastuzumab-deruxtecan – Cancer du sein HER2+ métastatique
4小时前
求助中
Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
4小时前
已完结
皖公网安备34019202002308
